HRP931292B1 - Carbazolone derivatives and the process for preparing the same - Google Patents

Carbazolone derivatives and the process for preparing the same

Info

Publication number
HRP931292B1
HRP931292B1 HR3223/92A HRP931292A HRP931292B1 HR P931292 B1 HRP931292 B1 HR P931292B1 HR 3223/92 A HR3223/92 A HR 3223/92A HR P931292 A HRP931292 A HR P931292A HR P931292 B1 HRP931292 B1 HR P931292B1
Authority
HR
Croatia
Prior art keywords
formula
methyl
group
chem
same
Prior art date
Application number
HR3223/92A
Other languages
English (en)
Inventor
Erika Horvath
Original Assignee
Erika Horvath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26318102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP931292(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from HU9203222A external-priority patent/HU212934B/hu
Priority claimed from HU9203223A external-priority patent/HU212785B/hu
Application filed by Erika Horvath filed Critical Erika Horvath
Publication of HRP931292A2 publication Critical patent/HRP931292A2/hr
Publication of HRP931292B1 publication Critical patent/HRP931292B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR3223/92A 1992-10-14 1993-10-08 Carbazolone derivatives and the process for preparing the same HRP931292B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9203222A HU212934B (en) 1992-10-14 1992-10-14 Process for producing novel alkoxalylated carbazolone derivatives
HU9203223A HU212785B (en) 1992-10-14 1992-10-14 Process for producing of a carbazolone derivative

Publications (2)

Publication Number Publication Date
HRP931292A2 HRP931292A2 (en) 1994-12-31
HRP931292B1 true HRP931292B1 (en) 1999-08-31

Family

ID=26318102

Family Applications (1)

Application Number Title Priority Date Filing Date
HR3223/92A HRP931292B1 (en) 1992-10-14 1993-10-08 Carbazolone derivatives and the process for preparing the same

Country Status (20)

Country Link
US (2) US5416221A (cs)
EP (1) EP0595111B2 (cs)
JP (1) JP3378315B2 (cs)
KR (1) KR100289912B1 (cs)
CN (2) CN1052979C (cs)
AT (1) ATE157973T1 (cs)
CA (1) CA2106642C (cs)
CZ (1) CZ284223B6 (cs)
DE (1) DE69313771T3 (cs)
DK (1) DK0595111T4 (cs)
EE (1) EE03071B1 (cs)
ES (1) ES2106936T5 (cs)
GR (1) GR3025599T3 (cs)
HR (1) HRP931292B1 (cs)
PL (2) PL174526B1 (cs)
RO (1) RO115799B1 (cs)
RU (1) RU2119914C1 (cs)
SI (1) SI9300537B (cs)
SK (1) SK281243B6 (cs)
UA (2) UA26893C2 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226135B1 (en) * 2000-03-28 2008-05-28 Richter Gedeon Nyrt Intermediate of ondansetron and process for its production
KR100368895B1 (ko) * 2000-03-30 2003-01-24 하나제약 주식회사 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법
AU2002230935A1 (en) * 2000-10-30 2002-05-15 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
RU2207340C2 (ru) * 2001-08-10 2003-06-27 Ципла Лтд. Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)метил]-4н-карбазол -4-она или его фармацевтически приемлемых солей
EP1499623B1 (en) * 2002-04-29 2007-06-13 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
JP2007501284A (ja) * 2003-06-10 2007-01-25 スミスクライン ビーチャム コーポレーション テトラヒドロカルバゾール誘導体およびそれらの薬学的使用
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
GEP20094682B (en) * 2004-07-12 2009-05-10 Cadila Healthcare Ltd Tricyclic pyrazole derivatives as cannabinoid receptor modulators
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
WO2006046253A1 (en) * 2004-10-26 2006-05-04 Ipca Laboratories Limited A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o
CN101084190B (zh) * 2004-12-27 2011-01-26 埃科特莱茵药品有限公司 作为crth2受体拮抗剂的2,3,4,9-四氢-1h-咔唑衍生物
CN115677561B (zh) * 2022-11-01 2024-04-05 常州兰陵制药有限公司 一种1,2,3,4-四氢-9-甲基-4h-咔唑酮及其合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
PH22672A (en) * 1984-01-25 1988-11-14 Glaxo Group Ltd Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
CN1011237B (zh) * 1984-01-25 1991-01-16 格拉克索公司 1，2，3，9-四氢-3-[(2-甲基-1h-咪唑-1-基)甲基]-4h-咔唑-4-酮类和其盐以及溶剂化物的制备
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
GB8628473D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Chemical compounds
JPH01258673A (ja) * 1987-10-22 1989-10-16 Glaxo Group Ltd ケトン誘導体

Also Published As

Publication number Publication date
EE03071B1 (et) 1998-02-16
DK0595111T3 (da) 1998-04-14
PL174173B1 (pl) 1998-06-30
SK111093A3 (en) 1994-11-09
CA2106642C (en) 2005-08-16
EP0595111B1 (en) 1997-09-10
PL300685A1 (en) 1994-04-18
RO115799B1 (ro) 2000-06-30
KR100289912B1 (ko) 2001-09-17
CA2106642A1 (en) 1994-04-15
PL174526B1 (pl) 1998-08-31
UA26893C2 (uk) 1999-12-29
JP3378315B2 (ja) 2003-02-17
CN1052979C (zh) 2000-05-31
CN1089941A (zh) 1994-07-27
ES2106936T3 (es) 1997-11-16
HRP931292A2 (en) 1994-12-31
EP0595111B2 (en) 2001-08-16
US5478949A (en) 1995-12-26
SI9300537A (en) 1994-06-30
CN1083430C (zh) 2002-04-24
US5416221A (en) 1995-05-16
JPH06293734A (ja) 1994-10-21
SK281243B6 (sk) 2001-01-18
ATE157973T1 (de) 1997-09-15
DE69313771T2 (de) 1998-02-12
ES2106936T5 (es) 2001-12-16
DK0595111T4 (da) 2001-10-22
CZ284223B6 (cs) 1998-09-16
CZ215693A3 (en) 1994-05-18
SI9300537B (sl) 2003-02-28
DE69313771D1 (de) 1997-10-16
KR940009152A (ko) 1994-05-20
DE69313771T3 (de) 2002-04-18
UA27022C2 (uk) 2000-02-28
CN1235967A (zh) 1999-11-24
RU2119914C1 (ru) 1998-10-10
EP0595111A1 (en) 1994-05-04
GR3025599T3 (en) 1998-03-31

Similar Documents

Publication Publication Date Title
GR3025599T3 (en) the same Carbazolone derivatives and process for preparing
TW262474B (cs)
HUT57722A (en) Process for producing azaspiran derivatives and pharmaceutical compositions comprising such compounds
BG105925A (en) Novel tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
HUT47550A (en) Process for producing tetrazole derivatives
IL99443A0 (en) Heterocyclic derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL98862A0 (en) Process for the preparation of biphenylcarbonitrile derivatives
IL110161A0 (en) 2-[1-(1,3-thiazolin-2-yl) azetidin-3-yl] Thio-carbapenem derivatives, their preparation and pharmaceutical compositions containing them
IL101012A0 (en) Pyranyl cyanoguanadine derivatives,processes for the preparation thereof and cardioplegic solution containing the same
AU1120095A (en) Novel imidazole derivative and process for producing the same
ZA93823B (en) Process for the preparation of taxane derivatives.
GR3018543T3 (en) Process for the preparation of baccatin iii and 10-deacetyl baccatin iii derivatives
TW255886B (cs)
EP0573667A4 (cs)
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
HUT59378A (en) Process for producing urea derivatives and pharmaceutical compositions comprising such compounds
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
HU9200172D0 (en) Substituted 1,2,3,4-tetrahydro-cyclopenta/b/indole-and 1,2,3,3a,4,8a-hexahydro-cyclopenta/b/indole derivatives, their intermediate products, process for their production and medical preparations containing them
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
GR3036403T3 (en) Process for the preparation of sulfonylurea derivatives and intermediates for this process
EP0250755A3 (en) Fluorine derivatives of vitamin d3 and process for producing the same
ZA924888B (en) Process for the synthesis of enantiomers of 3-aminochroman compounds
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
AU2639999A (en) Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20070830

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20081009